Assure to Attend Investor Conferences in December 2021

Rhea-AI Summary

Assure Holdings Corp. (NASDAQ: IONM) announced participation in two key investor conferences in December 2021. The Benchmark Company’s Discovery One on One Virtual Video Investor Conference is on December 2, focusing on micro-cap companies. Sidoti’s Virtual Microcap Investor Conference is set for December 8-9, with CEO John Farlinger scheduled to present on December 8 at 1:45 p.m. ET. Assure provides comprehensive intraoperative neuromonitoring services, recognized for high patient care standards and holding the Joint Commission’s Gold Seal of Approval.

DENVER, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services (“IONM”), announced that management will participate in the following investor conferences in December 2021:

• The Benchmark Company’s Discovery One on One Virtual Video Investor Conference December 2, 2021. The event will be showcasing dynamic publicly traded micro-cap companies. Qualified investors who would like to register for the conference can contact Vince Curatola, Director of Corporate Marketing Services at vcuratola@benchmarkcompany.com.
• Sidoti’s Virtual Microcap Investor Conference December 8-9, 2021. Assure’s executive chairman and CEO John Farlinger is scheduled to present on December 8^th at 1:45 p.m. ET. Management will be participating in virtual one-on-one meetings with institutional investors. Register for the webcast here: https://sidoti.zoom.us/webinar/register/WN_2i5G4oNxSW2g2QFix5ZAtA

About Assure Holdings
Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned the Joint Commission’s Gold Seal of Approval®. For more information, visit the company’s website at www.assureneuromonitoring.com.

Forward-Looking Statements
This news release may contain “forward-looking statements” within the meaning of applicable securities laws, including, but not limited to: the expected attendees of the conferences; and the Company’s ability to meet with the attendees. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to: the expected attendees may not attend one or more of the conferences; the Company may not meet with the targeted investors at the conferences; the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company’s operations and economic activity in general; and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com, which risks and uncertainties are incorporated herein by reference. Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
1-720-287-3093
Scott.Kozak@assureiom.com

John Farlinger, Chief Executive Officer
Assure Holdings Corp.
1-604-763-7565
John.Farlinger@assureiom.com

FAQ

What is Assure Holdings' participation in the December 2021 investor conferences?

Assure Holdings will participate in the Benchmark Company’s Discovery One on One Virtual Video Investor Conference on December 2 and Sidoti’s Virtual Microcap Investor Conference on December 8-9.

Who will present at the Sidoti Virtual Microcap Investor Conference for Assure Holdings?

CEO John Farlinger is scheduled to present on December 8, 2021, at 1:45 p.m. ET.

How can investors register for the Sidoti Virtual Microcap Investor Conference?

Investors can register for the event at the Sidoti conference webpage: https://sidoti.zoom.us/webinar/register/WN_2i5G4oNxSW2g2QFix5ZAtA.

What services does Assure Holdings provide?

Assure Holdings offers intraoperative neuromonitoring services during invasive surgeries, ensuring high standards of patient care.

What recognition has Assure Holdings received?

Assure Holdings has earned the Joint Commission’s Gold Seal of Approval for its patient care quality.